How Engaging Patients in Trial Design Maximizes Orphan Drug Success

Implementing the patient's voice in clinical trials

Read more

In the following Journal for Clinical Studies article, Worldwide’s Dr. Michael Murphy, Chief Medical and Scientific Officer, and Barbara Zupancic, Senior Director of Patient Recruitment and Retention, discuss the elements of a patient-centric trial design, in addition to high-quality patient engagement and its impact on orphan drug success.

Want to learn more about Worldwide Clinical Trials?